Search Tips

Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression]

UID: 10702

Author(s): Chen, Yingbei*, Skanderup, Anders J., Reuter, Victor*, Hsieh, James J.*, Zhao, Jeffrey * MSK affiliated

Core Facilities: Integrated Genomics Operation (IGO)

Description
Summary from the GEO: "Renal cell carcinomas with unclassified histology (uRCC) constitute a significant portion of aggressive non-clear cell RCC (nccRCC) that have no standard therapy. The oncogenic drivers in these tumors are unknown. We performed a molecular analysis of 62 high-grade primary uRCC, incorporating targeted cancer gene sequencing, RNA sequencing, Single Nucleotide Polymorphism array, fluorescence in-situ hybridization, immunohistochemistry, and cell-based assays. We identified recurrent somatic mutations in 29 genes, including NF2 (18%), SETD2 (18%), BAP1 (13%), KMT2C (10%), and MTOR (8%). Integrated analysis revealed distinct molecular subsets, including a subset of 26% uRCC characterized by NF2-loss, dysregulated Hippo-YAP pathway and worse survival.
Analysis of RNA from uRCC with or without NF2-loss."
Subject of Study
Subject(s)
OncoTree Cancer Type(s)
Renal Cell Carcinoma
Access via GEO

GZip and CSV Sequencing Data
Accession #: GSE85897

Access via SRA

RNA Sequence reads for 7 samples.
Accession #: SRP082503

Access via BioProject

Additional information about overall initiative.
Accession #: PRJNA339705

Access Restrictions
Free to All
Access Instructions
The NCBI Gene Expression Omnibus, SRA, and BioProject databases provide open access to these files.
Associated Publications
Data Type
Equipment Used
Illumina HiSeq 2500
Dataset Format(s)
CSV, SRA, gzip
Dataset Size
809.6 Kb (CSV), 55.583 Gb (SRA)
Data Catalog Record Updated
2023-12-07